Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03221127 |
|
Recruitment Status :
Active, not recruiting
First Posted : July 18, 2017
Last Update Posted : April 18, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Cardiovascular Diseases Diabetes Metabolic Syndrome Cancer Inflammatory Disease Atherosclerosis Cognitive Decline Liver Diseases Death Pain, Chronic Depression Infection Chronic Disease |
STUDY POPULATION The Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD) is an on-going prospective, population-based cohort study of risk factors for cardiovascular diseases, other chronic diseases and metabolic conditions in a sample of men from eastern Finland. The baseline examinations were carried out between 1984 and 1989, when 2,682 men (82.9% of those eligible) who were 42, 48, 54 or 60 years old were recruited. The first cohort consisted of 1166 men who were 54 years old, enrolled in 1984-1986, and the second cohort included 1516 men who were 42, 48, 54 or 60 years old, enrolled in 1986-1989. The baseline examinations were followed by the 4-year examinations (1991-1993), in which 1038 men from the second cohort (88% of the eligible) participated. At the 11-year examinations (1998-2001), all men from the second cohort were invited and 854 men (95% of the eligible) participated. These examinations were also the baseline for 920 postmenopausal women (78.4% of the 1173 eligible women) from the same area, aged 53-73 years. During the 20-year examination round, all men from the first and second baseline cohorts and all women were invited to the study site, and a total of 1241 men (80% of the eligible) and 634 women (81.0%) participated.
ASSESSMENT OF DIETARY INTAKES Food consumption has been assessed with an instructed food recording of four days, one of which was a weekend day, by household measures. A picture book of common foods and dishes was used to help in estimation of portion sizes. For each food item the participant could choose from 3-5 commonly used portion sizes or describe the portion size in relation to those in the book. In order to further improve accuracy, instructions were given and completed food records were checked by a nutritionist together with a participant. Nutrient intakes were estimated using the NUTRICA® 2.5 software (Social Insurance Institution, Turku, Finland). The databank of the software is mainly based on Finnish values of nutrient composition of foods.
OUTCOME ASSESSMENT Registration of the incidence of major chronic diseases and deaths during the follow up is based on the national registries (Hospital discharge registry, Cause of death register, Social Insurance Institution of Finland register for reimbursement of medicine expenses) by use of the Finnish personal identification code (social security number), and/or on findings at the re-examination rounds (such as fasting plasma glucose or 2-h oral glucose tolerance test to define type 2 diabetes in addition to data from the national registries).
| Study Type : | Observational |
| Actual Enrollment : | 2682 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Kuopio Ischaemic Heart Disease Risk Factor Study (Nutrition Component) |
| Actual Study Start Date : | March 1, 1984 |
| Estimated Primary Completion Date : | December 31, 2052 |
| Estimated Study Completion Date : | December 31, 2052 |
- Cardiovascular disease [ Time Frame: Annually between March 1984 and December 2052 ]Incidence of cardiovascular disease
- Carotid atherosclerosis [ Time Frame: From baseline to 4-y, 11-y and 20-y examinations ]Progression of common carotid artery - intima-media thickness (CCA-IMT)
- Death [ Time Frame: Annually between March 1984 and December 2052 ]Incidence of death
- Type 2 diabetes [ Time Frame: Annually between March 1984 and December 2052 ]Incidence of type 2 diabetes
- Dementia [ Time Frame: Annually between March 1984 and December 2052 ]Incidence of dementia
- Cancer [ Time Frame: Annually between March 1984 and December 2052 ]Incidence of cancer
- Infectious disease [ Time Frame: Annually between March 1984 and December 2052 ]Incidence of hospitalization due infectious disease
Biospecimen Retention: Samples With DNA
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 42 Years to 73 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Aged 42, 48, 54 or 60 years (men at baseline in 1984-1989)
- Aged 53 to 73 years (women at their baseline in 1998-2001)
- Living in the city of Kuopio or neighboring rural areas
Exclusion Criteria:
- Condition that prevented visit at study clinic
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03221127
| Principal Investigator: | Jussi Kauhanen, MD, PhD | University of Eastern Finland, Institute of Public Health and Clinical Nutrition |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | University of Eastern Finland |
| ClinicalTrials.gov Identifier: | NCT03221127 |
| Other Study ID Numbers: |
KIHD Nutrition |
| First Posted: | July 18, 2017 Key Record Dates |
| Last Update Posted: | April 18, 2019 |
| Last Verified: | April 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | Data available for collaborative projects |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Liver Diseases Cardiovascular Diseases Heart Diseases Atherosclerosis Myocardial Ischemia Coronary Artery Disease Metabolic Syndrome Chronic Disease Chronic Pain Cognitive Dysfunction Digestive System Diseases Insulin Resistance Hyperinsulinism |
Glucose Metabolism Disorders Metabolic Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Disease Attributes Pathologic Processes Cognition Disorders Neurocognitive Disorders Mental Disorders Coronary Disease Pain Neurologic Manifestations |